NVO
Novo-Nordisk A/S
stockNYSEADR
At CloseOct 22, 2026 3:59:58 PM EDT
39.44USD+0.986%(+0.38)8,513,502
Pre-marketOct 22, 2026 9:29:30 AM EDT
39.41USD+0.896%(+0.35)
After-hoursOct 22, 2026 4:59:30 PM EDT
39.35USD-0.241%(-0.10)
Loading…
Loading…
174.16B
Healthcare
Biotechnology
HQ
Bagsvaerd, Bagsvaerd, Denmark
57,089
Previous Close
$39.06
Beta
1.02
52-Week High
$64.16 2026-01-23
52-Week Low
$35.12 2026-03-30
SMA 50
$42.20
SMA 200
$44.86
Avg. Vol 10D
9.81M
Avg. Vol 30D
13.33M
Avg. Vol 90D
12.16M
Relative Vol
0.53
4.41B
3.17B
71.90%
31,622,458
1.00%
1.74
54%/46%
44.90%
24.18%
0.3000%
10,000,000
192
7,421
22,844
Nov 4, 2026 (12d)
Mar 31, 2025 · $1.099
Sep 20, 2023 · 2-for-1
Oct 22, 2026
What Is the Peptide Economy? Beyond the GLP-1 Boom · 
ETF Trends
Bristol Myers Squibb vs. Novo Nordisk: Stable Scale vs. GLP-1 Volatility · 
The Motley Fool
Oct 21, 2026
Where Will Novo Stock Be in 10 Years? · The Motley Fool
NVO Profile
Novo Nordisk A/S is a Danish multinational pharmaceutical company headquartered in Bagsværd, Denmark, with production facilities in nine countries and affiliates or offices in five countries.
NVO Performance
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 39.22 | 2026-10-15 | +0.63% | 0.613 |
| 1M | 39.40 | 2026-09-22 | +0.17% | 0.788 |
| 3M | 48.19 | 2026-07-22 | -18.11% | -0.326 |
| 6M | 39.15 | 2026-04-22 | +0.81% | 0.111 |
| 1Y | 53.38 | 2025-10-22 | -26.07% | 1.021 |
| 2Y | 116.47 | 2024-10-22 | -66.12% | — |
| 5Y | 53.01 | 2021-10-22 | -25.55% | 0.672 |
NVO Stock Summary
Novo-Nordisk A/S (NYSE:NVO) stock price today is $39.47, and today's volume is 7,005,750. NVO is up 1.037% today. The 30 day average volume is 13.33M. NVO market cap is $174.16B with 4.41B shares outstanding.